Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2020-12-14 Investor Presentation
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
109年12月法人說明會簡報 — 316420201211M001.pdf
Investor Presentation Classification · 70% confidence The document text is heavily fragmented and contains many omitted images and partial text snippets. The content appears to focus on market outlook, product information, and some financial data related to probiotics and biotech markets. There is no clear indication of a formal financial report such as an Annual Report (10-K) or Interim Report (IR). The text does not contain structured financial statements or detailed management discussion. The document length is 4452 characters, which is relatively short and suggests it might be a presentation or summary rather than a full report. There is no mention of shareholder votes, legal proceedings, or capital changes. The fragmented nature and focus on market and product information, along with some financial data, aligns best with an Investor Presentation (IP).
2020-12-14 Chinese
109年12月法人說明會簡報
Investor Presentation Classification · 90% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting (法人說明會), including date, time, location, and links to presentation materials. It is not a full report but rather information about an investor presentation event and related materials. The presence of presentation files and meeting details aligns with the definition of an Investor Presentation (IP). The document length is short and it does not contain financial statements or detailed analysis, so it is not an Annual Report or Interim Report. Therefore, the best classification is Investor Presentation (IP).
2020-12-14 Chinese
109年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements, no management discussion, no audit information, and no mention of any meeting or voting results. The document is very short (601 characters) and primarily provides a snapshot of financial guarantees and loans, which is typical of a regulatory compliance disclosure rather than a full report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement about financial guarantees and loans, which aligns best with the Regulatory Filings (RNS) category as a general compliance disclosure.
2020-12-10 Chinese
109年11月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company named 景岳 for the period 民國109年11月 (November 2020). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting requirements. The document length is only 767 characters, which is very short and contains no detailed financial statements or analysis. It is essentially a summarized revenue report, typical of a Fund Information / Factsheet (FS) or a brief financial summary. It does not contain comprehensive financial data or management discussion, so it is not an Annual Report (10-K) or Interim Report (IR). It is not an announcement of a report publication or regulatory filing. Therefore, the best fit is Fund Information / Factsheet (FS).
2020-12-10 Chinese
109年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, independent directors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. It includes data on share ownership by various insiders and their family members, with no financial statements or earnings data. The content is focused on insider share transactions and holdings rather than financial results, governance policies, or meeting materials. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider holdings and changes, not just an announcement or summary. Therefore, the appropriate classification is DIRS.
2020-12-03 Chinese
109年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and senior management. It lists individual holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, management changes, or meeting materials. There is no indication of a report or announcement of voting results, dividends, or capital changes. The document is a typical insider shareholding disclosure, which corresponds to Director's Dealing filings.
2020-12-03 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.